Sulforaphane
Broccoli-sprout compound that switches on the body's Nrf2 defense genes.
What is Sulforaphane?
Sulforaphane is a longevity supplement used for activate nrf2 antioxidant defenses. NutriDex grades the human evidence as Mixed. Sulforaphane is an isothiocyanate formed when you chew or crush broccoli and especially broccoli sprouts, where the precursor glucoraphanin meets the enzyme myrosinase. It is a potent activator of the Nrf2 pathway, which switches on antioxidant and detoxification genes. Human trials are broad but uneven. A meta-analysis of 10 small broccoli-sprout trials reported large blood-pressure reductions (systolic ~11 mmHg), but the best-powered glucose RCT (n=89, 2025) achieved only a 0.2 mmol/L fall in fasting glucose and missed its prespecified target. In autism, an early small trial was positive but the larger replication failed its primary outcome. Sulforaphane lowers gastric oxidative-stress markers but does not reliably eradicate H. pylori, and modestly improves elevated liver enzymes in fatty-liver studies. Effect sizes are inconsistent and bioavailability varies enormously between products, so claims should be read cautiously.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Lower blood pressureMeta-analysis of 10 broccoli-sprout trials shows ~11 mmHg systolic drop, but trials are small and heterogeneous. | Moderate | ↑ benefit · moderate | 1 |
| Lower fasting glucoseBest-powered prediabetes RCT (n=89) saw only 0.2 mmol/L drop, missing its prespecified primary endpoint. | Mixed | — no effect · negligible | 1 |
| Reduce gastric inflammation/oxidative markersTwo RCTs lowered gastric urease and malondialdehyde but neither eradicated H. pylori. | Moderate | ↑ benefit · moderate | 2 |
| Lower elevated liver enzymes (fatty liver)Single small RCT in men with fatty liver lowered ALT/y-GTP; not replicated. | Preliminary | ↑ benefit · small | 1 |
| Improve autism behavioral scoresEarly small positive RCT failed to replicate; larger trial missed its primary outcome. | Mixed | ↔ mixed | 2 |